Why I must tell the truth

Quote
anonymous said:
My Executive Summary was concise, articulate, accurate and contains all the relevant facts. Your’s reads like the narrative for a special on A&E, that was passed on for being overly dramatic. Keep trying, son. Hope this helps.
Click to expand...

They both sucked.

You two idiots are made for each other.

Blah, Blah.

The End.
 










































EVERYBODY WILL HAVE TO DEAL WITH SOMETHING DOWN THE ROAD. WHAT WILL IT BE DETERMINES WHO YOU ARE. I SIT DOWN WITH THE DOCTOR IS TOTAL BULL. YOU KNOW AND I KNOW HOW IT WAS DONE. TRY TO FIGURE OUT A WAY TO STAY CALM. WHEN YOU DECIDED TO UNDERSTAND THE CONSEQUENCES YOU HAVE A CHANCE!
 


















anonymousGuest
On November 18, 2016, FMCH received a subpoena under the False Claims Act from the United States Attorney for the Eastern District of New York (Brooklyn) seeking documents and information relating to the operations of Shiel Medical Laboratory, Inc., which FMCH acquired in October 2013. In the course of cooperating in the investigation and preparing to respond to the subpoena, FMCH identified falsifications and misrepresentations in documents submitted by a Shiel salesperson that relate to the integrity of certain invoices submitted by Shiel for laboratory testing for patients in long term care facilities. On February 21, 2017, FMCH terminated the employee and notified the United States Attorney of the termination and its circumstances. The terminated employee’s conduct is expected to result in demands for the Company to refund overpayments and to pay related penalties under applicable laws, but the monetary value of such payment demands cannot yet be reasonably estimated. The Brooklyn USAO continues to investigate a range of issues involving Shiel, including allegations of improper compensation (kickbacks) to physicians, and has disclosed that multiple sealed qui tam complaints underlie the investigation.
On December 12, 2017, the Company sold to Quest Diagnostics certain Shiel operations that are the subject of this Brooklyn subpoena, including the misconduct reported to the United States Attorney. Under the sale agreement, the Company retains responsibility for the Brooklyn investigation and its outcome. The Company continues to cooperate in the ongoing investigation
 






















































To effectively test for fraud, all relevant transactions must be tested across all applicable business systems and applications. Analyzing business transactions at the source level helps auditors provide better insight and a more complete view as to the likelihood of fraud occurring. It helps focus investigative action to those transactions that are suspicious or illustrate control weaknesses that could be exploited by fraudsters. Follow-on tests should be performed to further that auditor’s understanding of the data and to search for symptoms of fraud in the data.1

There is a spectrum of analysis that can be deployed to detect fraud. It ranges from point-in-time analysis conducted in an ad hoc context for one-off fraud investigation or exploration, through to repetitive analysis of business processes where fraudulent activity is likely to more likely to occur. Ultimately, where the risk of fraud is high and the likelihood is as well, organizations can employ an “always on” or continuous approach to fraud detection – especially in those areas where preventative controls are not possible or effective.

Once an organization gets started with data analysis, they usually find that they want to do more and dig deeper into the data. Modern organizations have increased management demands for information and the audit paradigm is shifting from the traditional cyclical approach to a continuous and risk-based model. Technology therefore offers a range of solutions, varying by the size and sophistication of the audit organization. From ad hoc analysis, through to repeatable automated procedures, and continuous auditing and monitoring, analytics provide insight into the integrity of financial and business operations through transactional analysis. Technology provides more accurate audit reports and better insight into the internal controls framework, and improves the ability to access and manage business risk.

I know you have done your exhaustive analysis, do you have any theories? Have you tested your theories? Questioned accounts, have you sent anyone with knowledge on gathering intelligence to these accounts posing as representatives. Ask the questions, these accounts will tell you the truth. All former Shiel representatives, and of course some current ones, have taken from Quest. The covenants are apparently meaningless. I assure you the commonalities are far to many to be a shear coincidence. When you are able to find these commonalities, test your theories by questioning accounts. You will have your answers.
 






Top Bottom
Back
Quote